Pombiliti™ +Opfolda™
POMBILITI™ and OPFOLDA™ are prescription medicines used in combination for the treatment of adults with late-onset Pompe disease weighing 88 pounds (40 kg) or more and who are not improving on their current enzyme replacement therapy (ERT).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
Pombiliti™ +Opfolda™ Referral Form
WHAT IT TREATS: |
MANUFACTURER: Amicus Therapeutics US, LLC |
CLASS: Miscellaneous Metabolic Agents |
PRESCRIBED BY: Various
|
HOW ADMINISTERED: Opfolda™ orally, followed by Pombiliti by IV Infusion |
FREQUENCY: Every other week
|
Length of infusion: 4 hours, plus one hour between Opfolda™ and Pombiliti™ |
